Please switch to landscape mode for the best experience.
BACK TO WHITEPAPER

Intelligent TPP

Written by -Gunmeet SinghLinkedIn,Ankush BatraLinkedIn,Rajan DuaLinkedIn,Yash KulshreshthaLinkedIn

Intelligent TPP

The Problem

Target Product Profiles guide some of the biggest decisions in drug development, yet most teams still build them by hand. Analysts sift through literature, trial registries, and internal documents, then stitch the findings into a slide deck or document. There is no single source of truth, so teams lose time hunting for the current version and lose confidence in whether it still holds.
  • No centralized platform: teams search across emails, SharePoint, and slide decks just to find the current TPP.
  • No visibility into changes: benchmarks and attributes get updated with little record of why, which erodes trust across teams.
  • Manual, slow research: analysts spend hours extracting data from literature and trial registries by hand.

A Single, AI-Driven Platform for TPP Management

Intelligent TPP gives pharmaceutical teams one platform to build, track, and update Target Product Profiles. GenAI-powered data extraction, automated version control, and role-based collaboration work together so every stakeholder works from the same current profile.
  • AI-driven data extraction: pulls TPP-relevant data directly from PubMed, ClinicalTrials.gov, and internal repositories.
  • Automated version control: keeps a single source of truth, so no one works from an outdated TPP.
  • Change tracking and justification: every update is logged and annotated, giving teams a clear record of why a benchmark changed.

Built for the Teams Who Own the TPP

If you work in R&D, medical affairs, or competitive intelligence, this paper speaks to the hours you spend keeping TPPs current.
  • Stop rebuilding from scratch. Pull benchmark data directly from public and internal sources instead of manually compiling it each time.
  • Know why something changed. Every benchmark update carries a documented rationale, so cross-functional teams can trust and act on it.
  • Collaborate without the email chain. Role-based access and real-time annotations replace scattered feedback across inboxes.
  • Always work from the current version. Automated version control ends the search for the latest file.

What Changes

  • Faster benchmarking, replacing hours of manual literature review
  • Fewer version conflicts, with one source of truth for every TPP
  • Clearer accountability through a documented change history
  • Broader visibility into competitive positioning for leadership and strategy teams
These outcomes come from replacing scattered documents with one governed platform.

What You'll Learn

  • How Intelligent TPP replaces manual research with AI-driven data extraction from PubMed and ClinicalTrials.gov.
  • How the Benchmarks Hub and TPPs Tab work together to manage the full TPP lifecycle.
  • Why change tracking and justification matter for cross-functional trust.
  • How role-based access and automated workflows support collaboration across R&D and medical affairs.
  • What the platform's AWS-based architecture means for security and scalability.

Complete the Brief Form to Download the White Paper

​

+1

By submitting this form, you agree to our Privacy Policy. Information provided by you may be collected and automatically stored in our database, and may be used for sending you additional information about ProcDNA and our services.

Partner with us

At the heart of our approach is a commitment to your success. We take time to understand your unique challenges and craft tailored solutions that drive meaningful results. Let's build something extraordinary together.